Healius Limited (ASX:HLS)
0.9750
+0.0200 (2.09%)
At close: Jan 9, 2026
Healius Market Cap
Healius has a market cap or net worth of 707.98 million as of January 9, 2026. Its market cap has decreased by -30.36% in one year.
Market Cap
707.98M
Enterprise Value
1.56B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since August 29, 2000, Healius's market cap has increased from 478.57M to 707.98M, an increase of 47.94%. That is a compound annual growth rate of 1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 707.98M | 7.73% |
| Dec 31, 2025 | 657.15M | -33.94% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.03B |
| Pro Medicus | 21.96B |
| Cochlear | 17.22B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 8.13B |
| Ansell | 4.77B |
| Mesoblast | 3.94B |
| Telix Pharmaceuticals | 3.81B |